| Recruiting | Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT) NCT07521930 | Johns Hopkins University | N/A |
| Recruiting | Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients NCT07287189 | Satellos Bioscience, Inc. | Phase 2 |
| Recruiting | Fear of Falling in Muscular Dystrophy NCT07129954 | Universita di Verona | N/A |
| Recruiting | Muscle Health Measurements Using Electrical Impedance Myography NCT07502989 | Beth Israel Deaconess Medical Center | — |
| Enrolling By Invitation | Phase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FS NCT06547216 | Avidity Biosciences, Inc. | Phase 2 |
| Recruiting | Rehabilitation in Muscular Dystrophies From the Hospital Facility to the Home: Pilot Project [RIMUDI] NCT06378203 | IRCCS Eugenio Medea | N/A |
| Recruiting | Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia NCT05724173 | Leigh R. Hochberg, MD, PhD. | N/A |
| Recruiting | Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02) NCT06094205 | Leigh R. Hochberg, MD, PhD. | N/A |
| Completed | Exploring Accessible Beauty for Individuals With Upper Extremity Deficits NCT05945784 | Casa Colina Hospital and Centers for Healthcare | — |
| Active Not Recruiting | Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) NCT05747924 | Avidity Biosciences, Inc. | Phase 1 / Phase 2 |
| Completed | Absorption, Metabolism, Excretion and Absolute Bioavailability of EDG-5506 in Healthy Volunteers NCT05730842 | Edgewise Therapeutics, Inc. | Phase 1 |
| Completed | Exercise Therapy for Patients with Muscle Dystrophies NCT05081791 | Universitat Pompeu Fabra | N/A |
| Completed | A Study to Assess the Feasibility of Non-invasive Dried Blood Sampling NCT05492734 | Edgewise Therapeutics, Inc. | Phase 1 |
| Completed | Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients NCT05479981 | Avidity Biosciences, Inc. | Phase 2 |
| Completed | Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation Toolkit NCT04468919 | Oregon Health and Science University | N/A |
| Active Not Recruiting | A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy NCT05126758 | Capricor Inc. | Phase 3 |
| Unknown | Schulze Muscular Dystrophy Ability Clinical Study NCT05409079 | AbiliTech Medical Inc. | N/A |
| Unknown | Expiratory Muscle Strength Training (EMST) in Neuromuscular Disorders NCT04009408 | University of Calgary | N/A |
| Active Not Recruiting | COMMAND Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis NCT05035823 | Synchron Medical, Inc. | N/A |
| Withdrawn | SWITCH II Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis NCT05041114 | Synchron Medical, Inc. | N/A |
| Active Not Recruiting | Defining Endpoints in Becker Muscular Dystrophy NCT05257473 | Virginia Commonwealth University | — |
| Completed | Assessment of Safety and Acute Effects of a Knee-hip Powered Soft Exoskeleton in Patients With Neuromuscular D NCT05200702 | Institut de Myologie, France | N/A |
| Completed | Assessment of Safety and Acute Effects of a Lower-limb Powered Dermoskeleton in Patients With Neuromuscular Di NCT05199246 | Institut de Myologie, France | N/A |
| Completed | Anti-inflammatory Diet Consultation for Those With Neuromuscular Disability NCT05881122 | Brock University | N/A |
| Recruiting | Spanish Natural History Study for LAMA2 Muscular Dystrophy NCT06924125 | Hospital Universitari Vall d'Hebron Research Institute | — |
| Completed | Cycle Exercise in Wheelchair Users With Muscular Dystrophy or Cerebral Palsy NCT04677010 | Rigshospitalet, Denmark | N/A |
| Completed | Bullying in Youth With Muscular Dystrophy and Congenital Myopathies NCT04733976 | Holland Bloorview Kids Rehabilitation Hospital | — |
| Completed | COVID-19 Pandemic and Parents of Disabled Children NCT04525742 | Gaziosmanpasa Research and Education Hospital | N/A |
| Unknown | Ablelite Pediatric Device Clinical Study NCT04308447 | AbiliTech Medical Inc. | N/A |
| Active Not Recruiting | NuroSleeve Powered Brace & Stimulation System to Restore Arm Function NCT04798378 | Thomas Jefferson University | N/A |
| Unknown | Limb-Girdle Muscular Dystrophy Type 2I in Norway NCT03930628 | University Hospital of North Norway | — |
| Completed | Myotonic Dystrophy Type 1 Aerobic Exercise Study NCT04187482 | McMaster University | N/A |
| Completed | Biomarker Development in LGMD2i NCT04202627 | ML Bio Solutions, Inc. | — |
| Completed | Evaluation of a Textile Scapula Orthosis NCT04154098 | Swiss Federal Institute of Technology | N/A |
| Unknown | Telerehabilitation in Proximal Muscle Weakness NCT04392518 | Koç University | N/A |
| Completed | Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD) NCT03981289 | Virginia Commonwealth University | — |
| Unknown | Diaphragm Ultrasound in Neuromuscular Disorders NCT04045158 | Centre d'Investigation Clinique et Technologique 805 | — |
| Completed | Transmembrane Electromyography (TM-EMG) for the Assessment of Neuromuscular Function in the Oropharynx NCT03986671 | Powell Mansfield Inc. | N/A |
| Recruiting | ECoG BMI for Motor and Speech Control NCT03698149 | Karunesh Ganguly | N/A |
| Completed | First Time in Human (FTIH) Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single and NCT03627494 | GlaxoSmithKline | Phase 1 |
| Completed | Device for Breathing Frequency Monitoring in Muscular Dystrophy NCT04313595 | IRCCS Eugenio Medea | N/A |
| Completed | LARA: Use of JACO2 Controlled by Joystick or by Voice Control System, in Muscular Dystrophy NCT04313049 | IRCCS Eugenio Medea | N/A |
| Completed | Wearability, Saefty and Usability Assessment for the Upper Limb Exoskeleton BRIDGE/EMPATIA NCT03951844 | Alessandra Pedrocchi | N/A |
| Completed | Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic Tomog NCT03490214 | University of Erlangen-Nürnberg Medical School | N/A |
| Unknown | Turkish Version of The Measure of Processes of Care (MPOC) NCT03508583 | Hacettepe University | — |
| Completed | A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy NCT03406780 | Capricor Inc. | Phase 2 |
| Completed | Pro-inflammatory Cytokines in Facioscapulohumeral Muscular Dystrophy (CYTOKINE-FSH) NCT04694456 | Centre Hospitalier Universitaire de Nice | N/A |
| Unknown | [BrainConnexion] - Neurodevice Phase I Trial NCT03811301 | National Neuroscience Institute | N/A |
| Recruiting | Observational Study to Observe Variations of Gait Parameters in Patients With Neuromuscular Diseases NCT06666816 | IRCCS Eugenio Medea | — |
| Completed | The Effectiveness of Participation-focused Interventions on Body Functions of Youth With Physical Disabilities NCT03851107 | McGill University | N/A |
| Completed | Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy NCT03179631 | PTC Therapeutics | Phase 3 |
| Completed | User-centred Assistive System for Arm Functions in Neuromuscular Subjects NCT03127241 | Politecnico di Milano | N/A |
| Withdrawn | Self-management Training for Parents With Chronic Muscular Dystrophia NCT02641275 | University Children's Hospital, Zurich | N/A |
| Unknown | Prognostic Factors , Morbidity and Mortality in Patients With Neuromuscular Disorders Admitted in ICU NCT02685215 | Centre d'Investigation Clinique et Technologique 805 | — |
| Completed | Safety and Efficacy of a Flavonoids- and omega3s-based Compound for the Treatment of Muscular Dystrophies NCT03317171 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | N/A |
| Terminated | European Home Mechanical Ventilation Registry NCT02315339 | ResMed | — |
| Unknown | Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies NCT02109692 | University Hospital, Montpellier | N/A |
| Terminated | An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy NCT02090959 | PTC Therapeutics | Phase 3 |
| Completed | Pilot Study of Cardiac MR in Patients With Muscular Dystrophy NCT02921321 | Children's National Research Institute | — |
| Withdrawn | Drisapersen Duchenne Muscular Dystrophy (DMD) Treatment Protocol NCT01890798 | GlaxoSmithKline | Phase 3 |
| Terminated | A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Sub NCT01803412 | BioMarin Pharmaceutical | Phase 3 |
| Completed | Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) NCT01826487 | PTC Therapeutics | Phase 3 |
| Completed | Power Over Pain (POP) Study NCT01800604 | University of Washington | N/A |
| Recruiting | Genetic and Physical Study of Childhood Nerve and Muscle Disorders NCT01568658 | National Institute of Neurological Disorders and Stroke (NINDS) | — |
| Completed | Dysferlinopathy Protein in Peripheral Blood Monocytes. NCT06507215 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | — |
| Completed | A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD) NCT01462292 | GlaxoSmithKline | Phase 2 |
| Terminated | Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy NCT01480245 | GlaxoSmithKline | Phase 3 |
| Completed | A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy NCT01254019 | GlaxoSmithKline | Phase 3 |
| Completed | Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy NCT01153932 | GlaxoSmithKline | Phase 2 |
| Completed | A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolerability in No NCT01128855 | GlaxoSmithKline | Phase 1 |
| Completed | Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial NCT02432885 | InCor Heart Institute | Phase 3 |
| Completed | Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy NCT00873782 | University of North Carolina, Chapel Hill | Phase 1 |
| Unknown | The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies NCT00674843 | GAAD Medical Research Institute Inc. | Phase 1 |
| Terminated | A Phase I/II, Open Label, Escalating Dose, Pilot Study to Assess Effect, Safety, Tolerability and PK of Multip NCT01910649 | BioMarin Pharmaceutical | Phase 2 |
| Completed | Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D) NCT00494195 | Nationwide Children's Hospital | Phase 1 |
| Completed | Quality of Life in Neuromuscular Disease NCT02895763 | CHU de Reims | — |
| Completed | Muscle Tissue Bank for Muscular Dystrophy NCT01950897 | Wake Forest University Health Sciences | — |
| Completed | Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD) NCT00027391 | FDA Office of Orphan Products Development | N/A |
| Available | Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 Skipping NCT07250737 | Avidity Biosciences, Inc. | — |